Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension (NCT06492291)

🧪 Interventions in This Study

• Enlicitide Decanoate (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (222 Sites)

Showing the first 25 of 222 sites.

• Alliance for Multispecialty Research, LLC ( Site 0027) — Daphne, Alabama
• G&L Research ( Site 0035) — Foley, Alabama
• Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0048) — Phoenix, Arizona
• National Heart Institute-Research ( Site 0029) — Beverly Hills, California
• Clinical Trials Research ( Site 0054) — Sacramento, California
• Velocity Clinical Research, Banning ( Site 0023) — San Bernardino, California
• Emerson Clinical Research Institute ( Site 0017) — Washington D.C., District of Columbia
• Excel Medical Clinical Trials ( Site 0010) — Boca Raton, Florida
• Alliance for Multispecialty Research, LLC ( Site 0037) — Doral, Florida
• Alliance for Multispecialty Research, LLC ( Site 0056) — Fort Myers, Florida
• Velocity Clinical Research, Hallandale Beach ( Site 0053) — Hallandale, Florida
• Jacksonville Center for Clinical Research ( Site 0025) — Jacksonville, Florida
• South Broward Research ( Site 0012) — Miramar, Florida
• Progressive Medical Research ( Site 0033) — Port Orange, Florida
• Clinical Research Trials of Florida ( Site 0006) — Tampa, Florida
• Clinical Site Partners, LLC dba Flourish Research ( Site 0004) — Winter Park, Florida
• East Coast Institute for Research, LLC ( Site 0020) — Macon, Georgia
• Healthcare Research Network - Chicago ( Site 0051) — Flossmoor, Illinois
• Synexus Clinical Research US - Evansville ( Site 0005) — Evansville, Indiana
• Midwest Institute For Clinical Research ( Site 0052) — Indianapolis, Indiana
• Alliance for Multispecialty Research, LLC ( Site 0001) — Lexington, Kentucky
• L-MARC Research Center ( Site 0011) — Louisville, Kentucky
• Velocity Clinical Research, Covington ( Site 0026) — Covington, Louisiana
• Velocity Clinical Research Rockville ( Site 0022) — Rockville, Maryland
• Arcturus Healthcare , PLC, Troy Internal Medicine Research Division ( Site 0018) — Troy, Michigan

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Hypercholesterolemia

• Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy — Baltimore, Maryland
• Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile — Addison, Illinois
• Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia — Clearwater, Florida
• A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia — Anniston, Alabama
• Causes and Natural History of Dyslipidemias — Bethesda, Maryland

Explore by condition: All Hypercholesterolemia clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.